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Abstract  
Objects: The liver plays a major role in the pathogenesis of type 2 diabetes. Moderately elevated liver enzymes are found in 
type 2 diabetes.  This study is designed to appraise the role of yoga on liver enzymes in geriatric type 2 diabetes and 
consequently, the study constantly monitored the improvement related to glycaemic control during the period of observation. 
Study design: A total number of 143 type 2 diabetes patients in an age group of 60-70 years with a history of diabetes for 5-
10 years and having poor glycaemic control (HbA1c > 8 %) residing in Kozhikode district, Kerala, India participated in this 
study in test and control group together. The subjects were divided into three groups according to their glycaemic control: 
group I with HbA1c 8.6 – 9.7 %, group II with HbA1c 9.8 – 10.7 % and group III with HbA1c 10.8 – 12.7 %. The yogic practice 
sessions for the test group lasted for three months for 90 minutes a day, 6 days a week, under the guidance and supervision 
of experienced trainers.  Each session was systematically divided into structural components with 15 minutes of 
pranayamas (breath controlling exercises), 10 minutes of warm up exrcises, 50 minutes of asanas (yogic postures) and 15 
minutes of supine relaxation in savasana. The control group, mean while, were asked to continue their routine activities like 
walking and other normal non specific exercises. Glucose, HbA1c, aspartate aminotransferase, alanine aminotransferase and 
γ- glutamyl transpeptidase were estimated on base line and after 90 days of all the participants. 
Results: The participants in the test group showed statistically significant (p<0.001) decrease in glucose, HbA1c, and activity 
of liver enzymes after yogic practice. 
Conclusions: After 90 days of yogic practices, significant reduction in the liver enzymes was achieved in test group, 
corresponding to the reduction in blood glucose and HbA1c levels. The findings of this study demonstrate the efficacy of yogic 
practice, as a therapeutic, preventative and protective agent in geriatric type 2 diabetes mellitus by normalizing the liver 
function tests along with betterment in their glycaemic condition. 
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INTRODUCTION 
 
     Individuals with type 2 diabetes have a higher incidence of 
liver function test abnormalities than individuals who do not have 
diabetes.  Mild chronic elevations of transaminases often reflect 
underlying insulin resistance. The liver plays a major role in the 
pathogenesis of type 2 diabetes. Increased activities of liver 
enzymes such as aspartate aminotransferase (AST), alanine 
aminotransferase (ALT) and γ-glutamyl transpeptidase (GGT) are 
indicators of hepatocellular injury. Increased activity of these markers 
is associated with insulin resistance1, metabolic syndrome and type 2 
diabetes.2, 3 A limited number of prospective studies have found that 
high activities of AST, ALT and GGT are associated with the 
occurrence of type 2 diabetes, irrespective of age.4   
     The prevalence of type 2 diabetes is increasing all over the 
world.  This trend is visible both in developed and in developing 
countries.  According to the Diabetic Atlas 2009, published by the 
International Diabetic Federation, the prevalence of type 2 diabetes 
in Indian population is estimated to be around 51 million, bestowing 
the country with the title “diabetic capital of the world”.5 Diabetes 
Mellitus is a slowly progressive disease, affecting most of the 
systems in the body and perpetually deteriorating their normal 
functions. The chronological age of 65 years as a definition of 
“elderly” has been accepted by most developed countries in the 
world.  In the year 2002, the number of elderly people in India was 
about 75 million and it is projected to rise to 9 % of the total 
population by 2016.  From the global perspective, the elderly will 
constitute one third of the total population of the world by 2050.  
Health economic models have suggested that benefits of treating 
glycaemia may be somewhat less in older, than in younger patients.6 
Clearly, there is a need for cost-effective prevention and 
management strategies for type 2 diabetes that address the multiple 
interrelated factors underlying this complex, devastating and 
increasingly common disorder. Interest in and the use of 
complementary and alternative medicine has recently expanded in 
many countries around the world. Through the use of complementary 
therapies, diabetes patients can be alleviated from complications due 
to the chronic course of the disease, the debilitation of complications 
and threat of death, as well as the complexities of treatment plans.7 
Of particular interest in this regard is yoga, an ancient mind–body 
discipline, originated in India over 4000 years ago.  Yoga has been 
widely used in India for the management of diabetes, hypertension 
and related chronic insulin resistance conditions.  The practice of 
yoga is rising steadily in the United States and other industrialized 
countries in recent decades.8 Many studies have proved the 
effectiveness of yoga.  These investigations include a vast range of 
disorder like cardiovascular disease, hypertension, asthma, immune 
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conditions and diabetes.  A few studies have examined the effect of 
yoga on insulin and glucoregulatory hormones.9 In this study we 
evaluated the effects of yoga on liver enzymes in individuals with 
type 2 diabetes mellitus. The study also monitored the improvement 
related to glycaemic control in the same time period. 
 
MATERIALS AND METHODS 
 
     Yoga has been traditionally considered to be an all in one 
remedy for many ailments including chronic ones.  This study was 
aimed at identifying a scientific base for the centuries old culture 
prevalent in many parts of India as well as in foreign countries.  
This study was carried out for a period of more than one year, to be 
accurate, from March 2009 to December 2010. This study was 
carried out among the patients who visited the Diabetology 
department of Malabar Institute of Medical Science, Kozhikode, 
Kerala, India followed by news paper advertisement. Many patients 
willfully turned out to be volunteers for the study.  A total number of 
143 patients, all of them are elderly, healthy and within the age group 
of 60 to 70 years were analyzed.  All of them were suffering from 
type 2 diabetes mellitus, with a history of 5 to 10 years and having 
poor glycaemic control (HbA1c > 8 %) residing  in Kozhikode District. 
The family background of all the patients was similar-they all belongs 
to the middle class and were literate.  Interestingly, all the 143 
patients were non-vegetarian with similar food habits and diet 
patterns.  They were asked to make no changes in their life style.  
Consequently they maintained the same food habits throughout the 
study.  All these volunteers consumed their regular medicines in 
same doses during the entire period of the study. The demographic 
characteristics are reported in Table 1. Those volunteers who were 
clinically diagnosed with complications like coronary artery disease, 
renal disease and malignancies were not included in the project.  
Patients co-operated in the study were informed prior to the project, 
thereby obtaining consent from them. The institutional ethics 
committee had also given green signal for the project. 
     The project started with an awareness program, informing 
patients the importance and health benefits of yoga in day to day life.  
Those who were interested in yogic practice joined in the test group 
and others remained as controls. Seventy three patients who joined 
in the test group, practiced yoga in Yogabharathy Yoga Centre, 
Vadakara, Kozhikode District. The sessions lasted for three months, 
90 minutes a day, 6 days a week, under the guidance and 
supervision of experienced trainers. The sessions were carried out in 
a meticulous way, with each individual getting personal attention 
during the entire period.  Each session was systematically divided 
into structural components with 15 minutes of pranayamas (breath 
controlling exercises), 10 minutes of warm up exercises, 50 minutes 
of asanas (yogic postures) and 15 minutes of supine relaxation in 
savasana. 
     Meanwhile, seventy patients in the control group were asked 
to continue their routine activities like walking and other normal non 
specific exercises. This control group was also asked not to begin 
any new activity during the phase of the study.  The total patients 
were again subdivided into three groups according to their HbA1c 
value. Group 1 with HbA1c 8.6 – 9.7 %, group II with 9.8 – 10.7 % and 
group III with 10.8 – 12.7 %.  Fasting blood glucose, HbA1c, AST, 
ALT, GGT (Siemens Dimension clinical chemistry analyzer, USA) 
and HbA1c (Bio-rad D 10 analyzer, USA) were assessed initially and 
after 90 days of all the participants. All estimates were presented as 
mean +/- SE. The volunteers were not given any information about 
the fact that they are being part of a project comparing them with a 
control group. Both the volunteers as well as the trainers were blind 
to the data analysis. 
 
Statistical analysis 
 
     The normality of the variables considered was tested using 
Kolmogorov - Smirnov test and we found that HbA1c and glucose 
were following the normal distribution and the liver enzymes were not 
following the normal distribution. So, we tested the effect of yogic 
practice on the levels of liver enzymes using Wilcoxon Signed Rank 
test and paired t- test for HbA1c and glucose. The difference between 
the levels of control and test group at base line values of liver 
enzymes were analyzed by Mann – Whitney Test and independent 
sample t- test for HbA1c and glucose. SPSS 16.0 program and 
Microsoft Excel 2003 were used to perform statistical analysis.  
Level of significance was set at p<0.05.
 
Table 1. Demographic characteristics of participants (Mean ± SD). 
 
 Test group Control group p value 
Number 73 70  
Age (Years) (Male/Female) 64 ± 4   
(47/26) 
62 ± 3.4 
(41/29) 
0.001 
Duration of diabetes (Years) 8 ± 2 8 ± 2 1.00 
BMI (kg/m2) 25.3 ± 3.2 25 ± 4.1 0.626 
Weight (kg) 68.2 ± 3.4 67.4 ± 4.2 0.214 
 
Table 2. HbA1c and glucose values before and after yogic practice of test group comparing with control in groups I, II & III. 
 
  HbA1c (%) Glucose (mg/dl) 
 No Before After p value % change after yoga Before After P value % change after yoga 
Group I 
Control 
Test 
37 
33 
9.27 ± 0.049 
9.40 ± 0.050 
p=0.075† 
9.36±0.057 
8.36±0.05 
0.005* 
0.000** 
11 
 
148.46±2.08 
179.7±6.23 
p =0.000 
150.97±2.28 
140±6.02 
 
0.05 * 
0.000** 
22 
Group II 
Control 
Test 
21 
26 
10.17±0.063 
10.17±0.046 
p=0.983† 
10.31±0.08
38.9±0.048 
0.000* 
0.000** 
12 179.81±6.63 
184.12±7.07 
p =0.659 † 
183.71±6.89 
146.81±5.53 
0.036 * 
0.000** 
20 
Group III 
Control 
Test 
12 
14 
11.48±0.187
11.22±0.069 
p=0.223† 
11.8±0.178 
10 ± 0.086 
0.000* 
0.00 ** 
12.2 235±11.57 
176.93 ± 8.7 
p = 0.001 
235.33±10.76 
142.21 ± 7.93 
0.922‡ 
0.000** 
19 
Values represent Mean ± SE.,† No significant difference in the initial readings of control and test, * Significant Increase ** Significant Decreasem ‡ Not significantly changed. 
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Table 3. Comparison of liver enzyme values before and after yogic practice of test group with control in groups I, II & III. 
 AST ALT GGT 
    Before After p value Before After p value Before After p value 
Group I 
Control 
Test 
41.68 ± 3.87 
51.61 ± 4.52 
p=0.022 
43.38 ± 4.31 
35.3 ± 2.27 
0.069‡ 
0.000** 
69.46 ± 4.3 
82.79 ± 7.23 
p=0.118† 
72.92 ± 5 
58.79 ± 3.64 
0.006* 
0.000** 
70.68 ± 5.83 
84.24 ± 11.46 
p=0.430† 
72.92 ± 6.13 
57.55 ± 6.18 
0.002* 
0.000** 
Group II 
Control 
Test 
50.52 ± 7.8 
52.77 ± 3.62 
p=0.101† 
52.14 ± 8.1 
36.41 ± 2.55 
0.082‡ 
0.000** 
73.14 ± 9.6 
77.88 ± 4.81 
p =0.042 
76.95 ± 9.95 
56.92 ± 2.67 
0.005* 
0.000** 
54.38 ± 3.56 
68.73 ± 5.39 
p =0.036 
55.52 ± 3.95 
49.81 ± 3.69 
0.255‡ 
0.000** 
 
Group III 
Control 
Test 
 
31.17 ± 1.14 
43.36 ± 3.24 
p =0.007 
 
30.33 ± 1.1 
31.5 ± 1.65 
0.592‡ 
0.001** 
55.58 ± 2.59 
68.93 ± 5.05 
p =0.053† 
55.58 ± 3.51 
52.14 ± 2.77 
0.720‡ 
0.001** 
60.42 ± 3.2 
72.5 ± 5.32 
p =0.085† 
62.42 ± 3.56 
58.57 ± 4.01 
0.049* 
0.001** 
Values represent Mean ± SE. † No significant difference in the initial readings of control and test * Significant Increase ** Significant Decrease ‡ Not significantly changed. 
Table 4. Change in liver enzymes (in percentage) after yogic practice in test groups. 
Variable Group I Group II Group III 
AST 31.6 31 27.3 
ALT 28.9 26.9 24.3 
GGT 31.6 27.5 19.2 
 
RESULTS 
 
     Out of the 143 geriatric type 2 diabetic patients, 61.5 % were 
males and 38.5 % females. Subjects were matched according to age 
and gender.  The mean age was similar in control and test groups.  
They were also similar in body weight and body mass index (Table 
1).  All the 143 patients completed the study by participating in the 
three months' assessment period.  Significant decrease (p =0.000) 
was observed for HbA1c after 3 months of yogic practice in test group 
I (9.40 ± 0.050 to 8.36 ± 0.05 %), group II (10.17 ± 0.046 to 8.9 ± 
0.048 %) and group III (11.22 ± 0.069 to 10 ± 0.086 %). In contrast 
to this, a significant increase with p=0.005 in control group I (9.27 ± 
0.049 to 9.36 ± 0.057 %), p=0.000 in control group II (10.17 ± 0.063 
to 10.31 ± 0.083 %) and p=0.000 in control group III (11.48 ± 0.187 
to 11.80 ± 0.178 %) was observed.  The percentage reduction in 
HbA1c of test group I, II & III was 11.0, 12.0 and 12.2 respectively 
(Table 2). There was also a significant decrease (p =0.000) observed 
in the test group for fasting glucose. For glucose in test group I the 
values decreased from 179.7 ± 6.23 mg/dl to 140 ± 6.02 mg/dl 
(20 %), in test group II the decrease was from 184.12 ± 7.07 mg/dl to 
146.81 ± 5.53 mg/dl (20 %) and in test group III the decrease was 
from 176.93 ± 8.7 mg/dl to 142.21 ± 7.93 mg/dl (19 %).  At the 
same time in control group I a significant increase (p=0.005) from 
148 ± 2.08 to 150.97 ± 2.28 mg/dl and in control group II a 
significant increase (p=0.036) from 179.81 ± 6.63 to 183.71 ± 6.89 
mg/dl were observed. No significant change was observed in control 
group III.   
     In the case of liver enzymes, for AST in test group I, the 
values significantly decreased (p=0.000) from 51.61 ± 4.52 to 35.3 
±2.27 IU/L and the % change after yogic practice was 31.6. In test 
group II, the values decreased significantly (p= 0.000) from 52.77 ± 
3.62 to 36.41 ± 2.55 IU/L and the change was 31 %.  In test group 
III, a significant decrease was observed (p= 0.001) from 43.36 ± 3.24 
to 31.5 ± 1.65 IU/L and the % change was 27.3 and there was no 
significant change observed in the control groups (Table 3).  For 
ALT in test group I, the values significantly decreased (p=0.000) from 
82.79 ± 7.23 to 58.79 ± 3.64 IU/L and the % change after yogic 
practice was 28.9. At the same time in control group I, a significant 
increase was observed (p = 0.006) from 69.46 ± 4.3 to 72.92 ± 5 
IU/L. In test group II, there was a significant decrease (p = 0.000) 
from 77.88 ± 4.81 to 56.92 ± 2.67 IU/L and the % change was 26.9.  
As in control group I, a significant increase (p = 0.005) from 73.14 ± 
9.6 to 76.95 ± 9.95 IU/L was observed in control group II also.  In 
test group III, a significant decrease was observed (p=0.001) from 
68.93 ± 5.05 to 52.14 ± 2.77 IU/L and 24.3 % of change was 
observed in values and without a significant change in control group 
III (Table 3).  In test group I, the GGT values significantly 
decreased (p=0.000) from 84.24 ± 11.46 to 57.55 ± 6.18 IU/L and 
the % change was 31.6 and in control group I, a significant increase 
was observed (p = 0.002) from 70.68 ± 5.83 to 72.92 ± 6.13 IU/L.  
In test group II, the values decreased significantly (p= 0.000) from 
68.73 ± 5.39 to 49.81 ± 3.95 IU/L and the change was 27.5 %.  No 
significant change was observed in the control values.  In test 
group III, a significant decrease (p=0.001) from 72.5 ± 5.32 to 58.57 
± 4.01 IU/L and 19.2 % of change was observed in the values.  In 
control group III, an increase from 60.42 ± 3.2 to 62.42 ± 3.56 IU/L 
was observed at p value 0.049 (Table 3). 
 
DISCUSSION 
 
     Following 90 days of yogic practice, a significant reduction in 
the liver enzymes was achieved in test group.  In the test group, 
before yogic practice, 64 % participants had elevated AST. ALT was 
elevated in 59 % and GGT in 19 %. Ayman et al., (2011) reported 
significant increase in liver enzymes of type 2 Sudanese diabetic 
patients.10 Studies regarding the effect of yogic practice on liver 
enzymes in type 2 diabetes are not reported.  The relationship 
between exercise and liver health is also not so clear.  A strong 
protective effect of physical activity on the risk of diabetes promotion 
and the regular physical activity prevent diabetes and cardiovascular 
disease in high-risk populations and also appears to be slightly 
protective against raised GGT level.11 
     Yoga’s approach to fitness is that it does not merely focus on 
visible physical health, but on the body as a whole. This means that 
it takes into account the relationship between physical, mental and 
emotional health and the need to maintain a proper balance in 
totality. Yoga, therefore acts as a balancing force, through its 
combination of physical postures, breathing techniques and 
meditation.12 Many of the yoga postures put gentle pressure or act as 
a massage on the internal organs, thereby stimulating it. Some 
postures improve circulation and some improve nervous system 
function.13 Breath exercises also improve circulation and cleanse the 
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system.14 Thus they indirectly improve liver function by balancing the 
various functions that do have an effect on liver function.   
     Various yoga-asanas may be directly rejuvenating the cells of 
pancreas as a result of which there may be an increase in the 
utilization and metabolism of glucose in the peripheral tissues, liver 
and adipose tissues through enzymatic processes15. A decrease in 
the drug requirements by some of the patients have also been 
reported.16 As the beneficial changes observed in the liver enzymes 
in this study, other several risk indices, including glucose tolerance 
and insulin sensitivity, lipid profiles, anthropometric characteristics, 
blood pressure, oxidative stress, coagulation profiles, sympathetic 
activation and pulmonary function, as well as improvement in specific 
clinical outcomes were also observed.8 
     Yogic practice with its change in posture and controlled 
breathing influences mental status of an individual, allaying 
apprehension, stress and brings about feelings of well being and 
hormonal balance.  Sense of well being seen in those practicing 
yoga is also believed to be due to the endogenous secretion of 
melatonin.17 Thus, it is not wrong to conclude that diabetes can be 
better controlled if yoga can also be simultaneously practiced along 
with conventional medicines.  
     From the group comparison, it was clear that the effect of 
yogic practice on liver enzymes was directly related to the glycaemic 
control in geriatric patients (Table 4). From this study, we observed 
that along with the improvement in glycaemic status, liver function 
also fell into normal level.  The impact of yogic practice was more 
visible for the group with better glycaemic control, ie., group I.  
From this we may conclude that with yogic practice alone, maximal 
benefits could be seen in patients with mild cases of diabetes.  
These findings demonstrate the efficacy of yogic practice, as a 
therapeutic, preventative and protective agent in geriatric type 2 
diabetes mellitus by normalizing the liver functions along with 
balancing the glycaemic condition. The major limitation of the 
present study according to the authors is that the subjects could not 
be kept under uniform, identical study environment. This is because 
all the subjects were staying in their homes with their families. Strict 
adherence to medication was another aspect. Subjects were regular 
in this respect was assumed, but could not be objectively verified. 
Changes in food habits might also have influenced the results, as the 
study was essentially on diabetic patients.  
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